Capital International Investors
MRNA icon

Capital International Investors’s Moderna MRNA Stock Holding History

Capital International Investors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-78,116
Closed -$9.28M – 450
2024
Q2 		$9.28M Sell
78,116
-559,020
-88% -$70.7M ﹤0.01% 397
2024
Q1 		$67.9M Buy
637,136
+23,286
+4% +$2.35M 0.01% 306
2023
Q4 		$61M Sell
613,850
-7
-0% -$589 0.01% 311
2023
Q3 		$63.4M Sell
613,857
-13,743
-2% -$1.53M 0.02% 306
2023
Q2 		$76.3M Sell
627,600
-728,177
-54% -$97.1M 0.02% 306
2023
Q1 		$208M Buy
+1,355,777
New +$224M 0.05% 230

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors's MRNA Position: Q3 2024 in Review

Capital International Investors sold out of Moderna (MRNA) in Q3 2024, closing a stake of 78,116 shares — an estimated $9.28M sold.

Capital International Investors first reported a position in MRNA in Q1 2023 and held it in 6 quarters. The position peaked at $208M in Q1 2023. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Capital International Investors reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Capital International Investors sold 78,116 Moderna shares in Q3 2024, an estimated $9.28M.
  • Capital International Investors first reported a position in Moderna in Q1 2023 and held it in 6 quarters.
  • Capital International Investors's Moderna position peaked at $208M in Q1 2023.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Capital International Investors's 13F filing for Q3 2024, filed 13 Nov 2024.